Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Myra Wick
Points to Consider: Is There Evidence to Support BRCA1/2 and Other Inherited Breast Cancer Genetic Testing for All Breast Cancer Patients? A Statement of the American College of Medical Genetics and Genomics (ACMG)
Genetics in Medicine
Medicine
Genetics
Related publications
The Use of ACMG Secondary Findings Recommendations for General Population Screening: A Policy Statement of the American College of Medical Genetics and Genomics (ACMG)
Genetics in Medicine
Medicine
Genetics
Women's Receptivity to Testing for a Genetic Susceptibility to Breast Cancer.
American Journal of Public Health
Environmental
Public Health
Occupational Health
Lurbinectedin Is Active in Patients With BRCA1/2 Mutant Breast Cancer
Cancer Discovery
Oncology
Polygenic Inherited Predisposition to Breast Cancer
Cold Spring Harbor Symposia on Quantitative Biology
Biochemistry
Genetics
Molecular Biology
A Prior Diagnosis of Breast Cancer Is a Risk Factor for Breast Cancer in BRCA1 and BRCA2 Carriers
Current Oncology
Oncology
Consensus Guidelines on Genetic` Testing for Hereditary Breast Cancer From the American Society of Breast Surgeons
Annals of Surgical Oncology
Oncology
Surgery
Noninvasive Prenatal Screening for Fetal Aneuploidy, 2016 Update: A Position Statement of the American College of Medical Genetics and Genomics
Genetics in Medicine
Medicine
Genetics
Venous Thromboembolism Laboratory Testing (Factor v Leiden and Factor II C.*97G>A), 2018 Update: A Technical Standard of the American College of Medical Genetics and Genomics (ACMG)
Genetics in Medicine
Medicine
Genetics
What Is the Best Risk-Reducing Decision for Breast Cancer Patients With BRCA1/2 Mutation?
Archives of Breast Cancer